Literature DB >> 18356302

Efficient gene delivery using reconstituted chromatin enhanced for nuclear targeting.

Kylie M Wagstaff1, Jun Y Fan, Michelle A De Jesus, David J Tremethick, David A Jans.   

Abstract

Nonviral gene delivery is hampered by difficulties associated with transporting negatively charged DNA through the cell membrane and, more importantly, the nuclear envelope of target cells. Here we show for the first time that chromatin reconstituted with histone H2B proteins optimized for nuclear targeting can be used as an efficient means to deliver DNA to the nucleus of intact living mammalian cells, resulting in high levels of transgene expression that were approximately 6-fold more than those achieved by commercial liposomal preparations. The high efficiency is due in part to DNA condensation and protection against degradation in the reconstituted chromatin, as well as its ability to interact with high affinity with the importin proteins of the cellular nuclear import machinery. "Chromofection," gene delivery by protein transduction using chromatin enhanced for nuclear targeting represents an efficient means to deliver DNA to a wide variety of cell types, with the potential to treat complex genetic disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18356302     DOI: 10.1096/fj.07-099911

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  13 in total

Review 1.  Nucleic acids in circulation: are they harmful to the host?

Authors:  Indraneel Mittra; Naveen Kumar Nair; Pradyumna Kumar Mishra
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

2.  Importin-4 Regulates Gene Delivery by Enhancing Nuclear Retention and Chromatin Deposition by Polyplexes.

Authors:  Nikki L Ross; Millicent O Sullivan
Journal:  Mol Pharm       Date:  2015-10-23       Impact factor: 4.939

3.  Histone-targeted gene transfer of bone morphogenetic protein-2 enhances mesenchymal stem cell chondrogenic differentiation.

Authors:  Erik V Munsell; Deepa S Kurpad; Theresa A Freeman; Millicent O Sullivan
Journal:  Acta Biomater       Date:  2018-03-02       Impact factor: 8.947

Review 4.  Novel delivery approaches for cancer therapeutics.

Authors:  Ashim K Mitra; Vibhuti Agrahari; Abhirup Mandal; Kishore Cholkar; Chandramouli Natarajan; Sujay Shah; Mary Joseph; Hoang M Trinh; Ravi Vaishya; Xiaoyan Yang; Yi Hao; Varun Khurana; Dhananjay Pal
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

5.  Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes.

Authors:  Indraneel Mittra; Naveen Kumar Khare; Gorantla Venkata Raghuram; Rohan Chaubal; Fatema Khambatti; Deepika Gupta; Ashwini Gaikwad; Preeti Prasannan; Akshita Singh; Aishwarya Iyer; Ankita Singh; Pawan Upadhyay; Naveen Kumar Nair; Pradyumna Kumar Mishra; Amit Dutt
Journal:  J Biosci       Date:  2015-03       Impact factor: 1.826

6.  Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus.

Authors:  Kylie M Wagstaff; Haran Sivakumaran; Steven M Heaton; David Harrich; David A Jans
Journal:  Biochem J       Date:  2012-05-01       Impact factor: 3.857

7.  Enhanced tumour cell nuclear targeting in a tumour progression model.

Authors:  Michael S Nastasie; Helmut Thissen; David A Jans; Kylie M Wagstaff
Journal:  BMC Cancer       Date:  2015-02-21       Impact factor: 4.430

Review 8.  The dark side of circulating nucleic acids.

Authors:  Silvia Gravina; John M Sedivy; Jan Vijg
Journal:  Aging Cell       Date:  2016-02-22       Impact factor: 9.304

9.  Physical shearing imparts biological activity to DNA and ability to transmit itself horizontally across species and kingdom boundaries.

Authors:  Gorantla Venkata Raghuram; Deepika Gupta; Siddharth Subramaniam; Ashwini Gaikwad; Naveen Kumar Khare; Malcolm Nobre; Naveen Kumar Nair; Indraneel Mittra
Journal:  BMC Mol Biol       Date:  2017-08-09       Impact factor: 2.946

10.  Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids.

Authors:  Tobias Killian; Annette Buntz; Teresa Herlet; Heike Seul; Olaf Mundigl; Gernot Längst; Ulrich Brinkmann
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.